69
Growth Score
pts
Heat Score
-9 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
478741
EndoRel Biosciences develops technology for targeted intracellular drug delivery.
- Jean Summerton: Co-Founder and Head of Chemistry
Jeremy Bushman: Co-Founder
About the Company
EndoRel Biosciences is an early-stage biotechnology startup that focuses on enhancing intracellular drug delivery. The company has developed a novel endosomal release platform designed for targeted intracellular delivery. This proprietary technology aims to improve the efficiency and effectiveness of drug delivery within cells, potentially
transforming therapeutic outcomes.
